preeclampsia
Biora Therapeutics Divests Preeclampsia Test to Avero Diagnostics
Biora previously operated as a women's health diagnostic company called Progenity, but in mid-2021 shifted its focus to drug delivery and therapeutics.
NICE Recommends PerkinElmer, Roche, Quidel Assays for Preeclampsia Testing
The four assays are PerkinElmer's Delfia Xpress PLGF 1-2-3 and Delfia Xpress sFlt-1/PLGF 1-2-3, Roche's Elecsys immunoassay sFlt-1/PLGF ratio, and Quidel's Triage PLGF Test.
Mirvie Raises $60M in Series B Funding
The company plans to use the funding to propel the clinical and commercial development of its Mirvie RNA testing platform for pregnancy health.
The South San Francisco-based startup recently published two studies showing the performance of its tests for predicting preterm birth and preeclampsia.
Paper-Based Test Being Developed to Improve Preeclampsia Diagnosis and for Decentralized Settings
Premium
The testing being developed at the University of Illinois at Chicago and Yale could make diagnosis of the condition more accessible in LMICs.